ASAHI INTECC CO. LTD.
Research ASAHI INTECC CO. LTD. (6XT) on Bullrun: valuation model: 28.5% overvalued, market cap EUR 5.07B, P/E 53.1, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6XT
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Valuation signal28.5% overvalued
- Market capEUR 5.07B
- P/E53.1
- Dividend yield1.2%
- Financial periodFY2025
- RevenueEUR 120.03B
- Revenue growth11.6%
- Net incomeEUR 12.74B
- Free cash flowEUR 31.97B
- Gross margin67.7%
Valuation Snapshot
Bullrun's latest valuation model marks ASAHI INTECC CO. LTD. as 28.5% overvalued; latest market cap is EUR 5.07B; P/E is 53.1; dividend yield is 1.2%.
About ASAHI INTECC CO. LTD.
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. The company operates through the Medical and Device segments. It provides percutaneous coronary intervention (PCI) guide wires, guiding catheters, balloon catheters, and penetration catheters for cardiology;
Frequently asked questions
Is ASAHI INTECC CO. LTD. overvalued or undervalued?
Bullrun's valuation model currently marks ASAHI INTECC CO. LTD. as 28.5% overvalued.
What is ASAHI INTECC CO. LTD.'s market cap?
ASAHI INTECC CO. LTD.'s market capitalization is EUR 5.07B.
What is ASAHI INTECC CO. LTD.'s P/E ratio?
ASAHI INTECC CO. LTD.'s price-to-earnings (P/E) ratio is 53.1.
Does ASAHI INTECC CO. LTD. pay a dividend?
ASAHI INTECC CO. LTD. has a dividend yield of 1.2%.
What does ASAHI INTECC CO. LTD. do?
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. The company operates through the Medical and Device segments.